NewsBenzingaFate Therapeutics在ASN Kidney Week 2026上公布FT819更新的1期临床数据:这是一款现货型、可按需供应的抗CD19 CAR T细胞候选产品,用于治疗伴狼疮性肾炎的SLE患者 Fate Therapeutics在ASN Kidney Week 2026上公布FT819更新的1期临床数据:这是一款现货型、可按需供应的抗CD19 CAR T细胞候选产品,用于治疗伴狼疮性肾炎的SLE患者 Benzinga 2026.10.26 11:02 (GMT+0) Open on Benzinga Other news Billionaires Walk Away From Alphabet in Q3 - Hedge Funds Google ‘How to Sell’ and Hit Enter $100 Invested In Visa 15 Years Ago Would Be Worth This Much Today Western Digital Gains, Seagate Flat As Nvidia’s Raised Outlook Lifts AI Storage Hopes Home Depot Posts Strongest Comps In 4 Years, Analysts Revise Price Targets TJ Maxx Parent Bets on Accelerating Sales This Holiday Season Why Is Coinbase Stock Falling on Wednesday?